Annovis Bio, Inc. (ANVS) Stock Skyrockets Following Success of Clinical Trial and Subsequent Public Offering
Annovis Bio, Inc. (ANVS) stock prices skyrocketed by a staggering 127.27% as of the market closing on May 21st, 2021, bringing the price per share up to an even USD$60.00. ANVS401 Study The company announced on May 21st, 2021 the success of its double-blind placebo-controlled study in the treatment of Alzheimer’s Disease. Patients treated with […]
Jiuzi Holdings, Inc. (JZXN) Stock Surges Shortly After its Initial Public Offering Closes
Jiuzi Holdings, Inc. (JZXN) stock prices were up by a promising 23.85% as of the market opening on May 21st, 2021, bringing the price per share up to $0.19 shortly after the trading day commenced. Closing of IPO The company announced on May 20th, 2021 the closing of its initial public offering (IPO) of common […]
Onconova Therapeutics, Inc. (ONTX) Stock Skyrockets Following Reverse Stock Split
Onconova Therapeutics, Inc. (ONTX) stock prices were down by a substantial 21.08% as of the market closing on May 20th, 2021, bringing the price per share down to USD$0.73 at the end of the trading day. Subsequent pre-market fluctuations saw the price skyrocket by a monumental 1235.62%, bringing the price per share up to USD$9.69. […]
Intec Pharma Ltd. (NTEC) Stock Trending Higher Following Progress on Merger with Decoy Biosystem
Intec Pharma Ltd. (NTEC) stock prices were up by 3.02% as of the market closing on May 20th, 2021, bringing the price per share up to USD$3.75 at the end of the trading day. Merger with Decoy Announced March 15th, 2021 saw NTEC announce that it had entered into a definitive agreement with Decoy Biosystems. […]
PolarityTE, Inc. (PTE) Stock Trending Down Shortly After Disclosure of Promising Q1 2021 Financials
PolarityTE, Inc. (PTE) stock prices were down by 6.62% as of the market closing on May 17th, 2021, bringing the price per share down to USD$0.912 at the end of the trading day. Promising Trajectory The company consolidated its prior guidance in the first quarter of the fiscal year 2021 in regard to the submission […]
Oragenics, Inc. (OGEN) Stock Undergoes Volatility Following Changes in Management and Board of Directors
Oragenics, Inc. (OGEN) stock prices were up by 3.32% as of the market closing on April 14th, 2021, bringing the price per share up to USD$0.6199 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock jump by 1.64%, bringing it up to USD$0.62. Net Loss Reports March 3rd, 2021 saw […]
Alterity Therapeutics Ltd. (ATHE) Stock Prices on the Rise Following Promising Progress of ATH434 Development
Alterity Therapeutics Ltd. (ATHE) stock prices were up by 8.77% as of the market closing on May 14th, 2021, bringing the price per share up to USD$1.24. Solid Liquidity Position In an update on company activities for the quarter ending 31st March 2021, ATHE announced a solid liquidity position of USD$32.8 million. Along with operational […]
Checkpoint Therapeutics, Inc. (CKPT) Stock Undergoes Volatility after Release of Q1 2021 Financial Reports
Checkpoint Therapeutics, Inc. (CKPT) stock prices were up 4.17% as of the market closing on May 11th, 2021, bringing the price per share up to USD$2.50. Subsequent pre-market fluctuations have seen the stock fall 9.20%, down to USD$2.27. Cosibelimab Development The company recently reported the continued advancement of the development of CKPT’s two lead drug […]
Precipio, Inc. (PRPO) Stock On the Rise Following Launch of AML HemeScreen Panel
Precipio, Inc. (PRPO) stock prices were up by 15.63% as of the market closing on May 10th 2021, bringing the price per share surging to USD4.44. Subsequent pre-market fluctuations saw the stock further climb by 4.05% to hit USD$4.62. Launch of AML HemeScreen Panel PRPO recently announced the launch of its new Acute Myeloid Leukemia […]
Obalon Therapeutics, Inc. (OBLN) Stock Skyrockets after Class-Action Lawsuit Controversy Dies Down
Obalon Therapeutics, Inc. (OBLN) stock prices skyrocketed by 30.45% as of the market closing on May 10th, 2021, bringing the price per share up to USD$2.87 at the end of the trading day. OBLN’s Merger with ReShape November 10th, 2020 saw the pioneer of the FDA-approved balloon system for obesity treatment announce that it had […]
